Answers are grounded in this paper and cite their sources.
This review focuses on recent developments in the use of natural products as therapeutics for Alzheimer's disease. The compounds span a diverse array of structural classes and are organized according to their mechanism of action, with the focus primarily on the major hypotheses. Overall, the review discusses more than 180 compounds and summarizes 400 references.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: